Evidence map›Paper›PMID 32395135›Full record

ArticleJournal of contemporary brachytherapy2020

Prolonged treatment planning can increase real rectal dose in 3D brachytherapy for cervical cancer.

Zuzana Vlachová, Martin Dolezel, Katerina Svozilova, Paulina Jaskova, Denisa Vitaskova, Marcel Matzenauer, Jan Stuk, Igor Hartmann

Open access · goldAbstract read
In one paragraph

Article in Journal of contemporary brachytherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zuzana VlachováDepartment of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
Martin DolezelDepartment of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
Katerina SvozilovaDepartment of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
Paulina JaskovaDepartment of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
Denisa VitaskovaDepartment of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic.
Marcel MatzenauerComprehensive Cancer Centre, Novy Jicin, Czech Republic.
Jan StukComprehensive Cancer Centre Multiscan, Pardubice, Czech Republic.
Igor HartmannFaculty of Medicine, Palacký University Olomouc, Olomouc, Czech Republic.
Palacký University Olomouc · CZCharles University · CZMuzeum Novojičínska · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to evaluate the influence of 3D brachytherapy planning time on the real dose distribution. MATERIAL AND

methods10 patients with cervical cancer were evaluated using 2 computed tomography (CT) scans brachytherapy. The first scan was performed after the insertion of UVAG applicators, and the second was done after creating the treatment plan, just before the irradiation of first and third fraction. Both plans were compared in terms of changes of volumes and differences in the dose for high-risk organs using GEC-ESTRO Working Group parameters.

resultsThe median planning time was 54 minutes (36-64 minutes). The absolute median change of volume for bladder, rectum, and sigmoid was 32.1 cm

conclusionsExtended treatment planning time for brachytherapy due to the changes in topography of small pelvis can lead to different dose in high-risk organs than previously planned. It seems that the most significant changes are related to rectum.

Indexed as

3D brachytherapycervical cancertreatment planning

Identifiers

PMID32395135
PMCPMC7207232
OpenAlexW3021052400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.